Cargando…
Promising Treatment Options for Axial Spondyloarthritis: An Overview of Experimental Pharmacological Agents
Axial spondyloarthritis (axSpA) is a chronic inflammatory condition that predominantly affects the axial skeleton. All patients receive conservative management measures which include physiotherapy, patient education and use of nonsteroidal anti-inflammatory drugs (NSAIDs). Those with significant act...
Autores principales: | Tahir, Hasan, Byravan, Swetha, Fardanesh, Armin, Moorthy, Arumugam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269276/ https://www.ncbi.nlm.nih.gov/pubmed/34257507 http://dx.doi.org/10.2147/JEP.S262340 |
Ejemplares similares
-
Is There a Correlation Between Patient-Reported Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Score and MRI Findings in Axial Spondyloarthropathy in Routine Clinical Practice?
por: Byravan, Swetha, et al.
Publicado: (2021) -
Classification Terminology and Definitions in Reporting of MRI in Axial Spondyloarthritis
por: Ramdin, Danishta, et al.
Publicado: (2017) -
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
por: Atzeni, Fabiola, et al.
Publicado: (2021) -
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
por: Jarlborg, Matthias, et al.
Publicado: (2020) -
Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)